AB Science S.A. (OTCMKTS:ABSCF) Sees Large Drop in Short Interest

AB Science S.A. (OTCMKTS:ABSCF) was the target of a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 500 shares, a decrease of 16.7% from the July 31st total of 600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

AB Science Price Performance

OTCMKTS:ABSCF opened at $1.06 on Friday. The firm has a 50 day moving average of $1.98 and a 200 day moving average of $2.67. AB Science has a 52 week low of $1.06 and a 52 week high of $1.06.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.